Similarly, studies have suggested that the oncogenic roles of the miR-181 family in breast cancer cells is achieved through targeting PHLPP2 and INPP4B phosphatases, thus accelerating cancer cell cycle progression and proliferative potential [26]. Here, PHLPP2 is linked to breast cancer.